JACOBS LEVY EQUITY MANAGEMENT, INC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 216 filers reported holding IMMUNOGEN INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q1 2022$451,000
-55.8%
94,826
-31.1%
0.00%
-57.1%
Q4 2021$1,021,000
+315.0%
137,574
+216.8%
0.01%
+250.0%
Q3 2021$246,000
-49.1%
43,424
-40.8%
0.00%
-33.3%
Q2 2021$483,000
+37.2%
73,329
+68.9%
0.00%0.0%
Q1 2021$352,000
-83.8%
43,424
-87.1%
0.00%
-84.2%
Q4 2020$2,173,000
+90.9%
336,853
+6.6%
0.02%
+58.3%
Q3 2020$1,138,000
-52.8%
316,101
-39.7%
0.01%
-53.8%
Q2 2020$2,412,000
+26.0%
524,437
-6.6%
0.03%
+4.0%
Q1 2020$1,915,000
-35.1%
561,630
-2.8%
0.02%
-13.8%
Q4 2019$2,951,000
+186.2%
578,014
+35.7%
0.03%
+123.1%
Q3 2019$1,031,000
+295.0%
425,998
+254.1%
0.01%
+225.0%
Q2 2019$261,000
-66.7%
120,300
-58.4%
0.00%
-63.6%
Q1 2019$784,000
-43.4%
289,140
+0.3%
0.01%
-54.2%
Q4 2018$1,384,000
-28.1%
288,405
+41.9%
0.02%
-11.1%
Q3 2018$1,924,000
-12.5%
203,207
-10.0%
0.03%
-22.9%
Q2 2018$2,198,000
+13.9%
225,864
+23.2%
0.04%
+9.4%
Q1 2018$1,929,000
-14.6%
183,334
-48.0%
0.03%
-20.0%
Q4 2017$2,260,000
-12.3%
352,524
+4.6%
0.04%
-20.0%
Q3 2017$2,578,000
+3.4%
337,024
-3.9%
0.05%
-5.7%
Q2 2017$2,493,000
+344.4%
350,634
+67.4%
0.05%
+430.0%
Q3 2016$561,000
-45.7%
209,500
-37.6%
0.01%
-52.4%
Q2 2016$1,034,000
-46.3%
335,600
+48.6%
0.02%
-48.8%
Q1 2016$1,925,000
+308.7%
225,900
+551.0%
0.04%
+355.6%
Q4 2015$471,000
+238.8%
34,700
+139.3%
0.01%
+200.0%
Q3 2015$139,000
-93.5%
14,500
-90.2%
0.00%
-92.7%
Q2 2015$2,132,000
+21.3%
148,228
-24.5%
0.04%
+36.7%
Q1 2015$1,758,000196,4280.03%
Other shareholders
IMMUNOGEN INC shareholders Q2 2022
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 600,000$3,870,0002.25%
CM Management, LLC 375,000$2,419,0002.24%
Consonance Capital Management LP 3,515,944$22,678,0002.12%
RA Capital Management 18,417,458$118,793,0001.66%
Kercheville Advisors, LLC 244,421$1,564,0000.85%
Redmile Group, LLC 10,528,179$67,907,0000.82%
Birchview Capital, LP 190,000$1,226,0000.71%
QVT Financial LP 1,375,900$8,875,0000.49%
Fernwood Investment Management, LLC 149,340$963,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$671,0000.21%
View complete list of IMMUNOGEN INC shareholders